Shares of Kenvue fell more than 10% on Friday after a report that Health and Human Services Secretary Robert F. Kennedy Jr. will likely link autism to the use of the company’s pain medication Tylenol in pregnant women. HHS will release the report that could draw that link this month, the Wall Street Journal reported. Kenvue said it has “continuously evaluated the science and [continues] to believe there is no causal link” between the use of acetaminophen, the generic name for Tylenol, during pregnancy and autism. Kenvue Inc. Tylenol brand pain reliever for sale at a pharmacy in New York, US, on Wednesday, March 27, 2024. Bloomberg | Bloomberg | Getty Images
Shares of Kenvue fell more than 10% on Friday after a report that Health and Human Services Secretary Robert F. Kennedy Jr. will likely link autism to the use of the company’s pain medication Tylenol in pregnant women.
HHS will release the report that could draw that link this month, the Wall Street Journal reported on Friday.
That report will also suggest a medicine derived from folate – a